Mutation analysis of peroxisome proliferator-activated receptor-gamma coactivator-1 (PGC-1) and relationships of identified amino acid polymorphisms to Type II diabetes mellitus
about
sameAs
Complexity of type 2 diabetes mellitus data sets emerging from nutrigenomic research: a case for dimensionality reduction?Potentiation of liver X receptor transcriptional activity by peroxisome-proliferator-activated receptor gamma co-activator 1 alphaPGC-1 coactivators: inducible regulators of energy metabolism in health and diseaseGenes and pathophysiology of type 2 diabetes: more than just the Randle cycle all over againMultiple environmental and genetic factors influence skeletal muscle PGC-1alpha and PGC-1beta gene expression in twinsThe estrogen-related receptor alpha (ERRalpha) functions in PPARgamma coactivator 1alpha (PGC-1alpha)-induced mitochondrial biogenesisGenetic association analysis of 13 nuclear-encoded mitochondrial candidate genes with type II diabetes mellitus: the DAMAGE studyEpigenetic regulation of PPARGC1A in human type 2 diabetic islets and effect on insulin secretionEvidence of an association between genetic variation of the coactivator PGC-1beta and obesityCoordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1Linking disease-associated genes to regulatory networks via promoter organizationNew methods for finding disease-susceptibility genes: impact and potentialPGC-1alpha deficiency causes multi-system energy metabolic derangements: muscle dysfunction, abnormal weight control and hepatic steatosisCandidate gene association study in type 2 diabetes indicates a role for genes involved in beta-cell function as well as insulin actionParkinson's disease, insulin resistance and novel agents of neuroprotectionNuclear receptor coregulators: modulators of pathology and therapeutic targetsNew insights into PGC-1 coactivators: redefining their role in the regulation of mitochondrial function and beyondGenetic and epigenetic factors are associated with expression of respiratory chain component NDUFB6 in human skeletal muscleA mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicineImpaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetesBioenergetics in human evolution and disease: implications for the origins of biological complexity and the missing genetic variation of common diseases.T2D-Db: an integrated platform to study the molecular basis of Type 2 diabetesDevelopment of a new set of reference genes for normalization of real-time RT-PCR data of porcine backfat and longissimus dorsi muscle, and evaluation with PPARGC1A.Genetic polymorphisms and weight loss in obesity: a randomised trial of hypo-energetic high- versus low-fat diets.The impact of severity of hypertension on association of PGC-1alpha gene with blood pressure and risk of hypertension.Association between PPARGC1A polymorphisms and the occurrence of nonalcoholic fatty liver disease (NAFLD).The PPARGC1A Gly482Ser polymorphism is associated with left ventricular diastolic dysfunction in menTwo new splice variants in porcine PPARGC1A.Mitochondria, bioenergetics, and the epigenome in eukaryotic and human evolutionColloquium paper: bioenergetics, the origins of complexity, and the ascent of man.Skeletal Muscle Nucleo-Mitochondrial Crosstalk in Obesity and Type 2 Diabetes.Minireview: the SRC family of coactivators: an entrée to understanding a subset of polygenic diseases?PPARGC1A rs3736265 G>A polymorphism is associated with decreased risk of type 2 diabetes mellitus and fasting plasma glucose levelAssociation and interaction analysis of PPARGC1A and serum uric acid on type 2 diabetes mellitus in Chinese Han populationThe common PPAR-gamma2 Pro12Ala variant is associated with greater insulin sensitivity.Impaired mitochondrial substrate oxidation in muscle of insulin-resistant offspring of type 2 diabetic patients.Brown adipose tissue and thermogenesis.Hypothalamic PGC-1α protects against high-fat diet exposure by regulating ERα.Testing the thrifty gene hypothesis: the Gly482Ser variant in PPARGC1A is associated with BMI in TongansGenome-wide analysis of DNA methylation differences in muscle and fat from monozygotic twins discordant for type 2 diabetes.
P2860
Q24289423-3094E7A7-C43E-4D71-800C-BBF45031E5CFQ24535642-615974BC-7551-4339-B3E4-D56B40A18489Q24541524-9B90A7A6-9A40-44E8-B38E-2EE21CBE912FQ24561554-3B49D3E7-42E6-4162-8C5F-43F51EF76F02Q24561604-E76233DA-9906-400D-8B4C-1D75F8D7160BQ24564869-A203A5E8-54AC-483B-8774-2831008A1A63Q24600599-84B1B210-1C00-43BB-B975-9FC889C26BF1Q24650896-A2CF7C5E-D83E-4795-8C90-B6270263AD15Q24673585-C91CDDF8-E032-4C5E-8452-BA725F6AB781Q24679555-37120C02-ADDF-49AA-86C7-DA3407AC2A87Q24791009-290AB736-CE4A-42DF-9C3C-5E8C8713A348Q24792574-EACFECCA-C6BC-49B9-B84F-2DB7C3D52032Q24798075-59FFE997-B5C7-4574-ADFB-42ACBF1F8058Q24803901-97E59316-B561-4340-BC54-C72BF57BE855Q26853311-6D076003-FF35-464E-829E-414452B436E7Q26859163-1E0DAB14-C477-4121-ACC4-1240E9412C5DQ26996576-4849F49E-51A5-4366-B815-0BE03C228824Q28756871-EC2653FF-BB35-47CF-964A-C710672DA1BDQ29547303-2CA9C5BF-1462-4F66-B508-7A36C3DB79E6Q29614548-38C43FFE-712F-4EE2-892A-3E0D33387E48Q30645106-435254B6-31DD-4F5E-974A-EE307CE6F8C5Q30844915-EB145694-0ABD-4022-8EFA-B8BA170D5FCCQ31065099-86C47327-7744-46A3-956A-B839E9569FB9Q33251921-676BEF1A-C62E-4AB4-80F7-ECF91949C1E7Q33304403-273CDCC4-A543-45AE-9E28-F7340963FD6EQ33347569-5F0A991C-D007-4462-BDC2-12C3851CF49EQ33392450-21E33F56-F174-490B-AD9E-A10E4F52EC8EQ33396368-4D73862C-4848-491F-94B5-EAFDC53F60B7Q33517075-4F2AC028-DE6B-40B5-963A-9575815F4F08Q33571732-53FA5251-BE8D-4469-AE59-3ED0AAF7C2ADQ33624769-DEB04323-1216-4E95-9690-EFCFD9C1A062Q33634287-F050E752-6FBF-4073-BA7D-CF74A4E642B4Q33913923-D5BAA0CC-21A8-4E1A-BFA5-B5C5D422D34CQ34309605-99D3C804-7727-46DE-BF2A-1EB64D750146Q34348367-AC359CA4-3AAE-4632-8B4B-A58ECDF036BCQ34370850-F486535E-8C7C-42D6-ACC7-1268762354F1Q34447547-A4033A78-3993-40C2-ABAB-1BCD2FFA620DQ34469234-58DFE403-0C3E-46BD-81E9-48B3A7710524Q34515923-C9A7BEE5-F325-424E-A5FB-66F1DCBB0A4BQ34516412-87909D8D-514D-4FF2-BEFE-56541D86A0DD
P2860
Mutation analysis of peroxisome proliferator-activated receptor-gamma coactivator-1 (PGC-1) and relationships of identified amino acid polymorphisms to Type II diabetes mellitus
description
2001 nî lūn-bûn
@nan
2001 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Mutation analysis of peroxisom ...... s to Type II diabetes mellitus
@ast
Mutation analysis of peroxisom ...... s to Type II diabetes mellitus
@en
Mutation analysis of peroxisom ...... s to Type II diabetes mellitus
@nl
type
label
Mutation analysis of peroxisom ...... s to Type II diabetes mellitus
@ast
Mutation analysis of peroxisom ...... s to Type II diabetes mellitus
@en
Mutation analysis of peroxisom ...... s to Type II diabetes mellitus
@nl
prefLabel
Mutation analysis of peroxisom ...... s to Type II diabetes mellitus
@ast
Mutation analysis of peroxisom ...... s to Type II diabetes mellitus
@en
Mutation analysis of peroxisom ...... s to Type II diabetes mellitus
@nl
P2093
P356
P1433
P1476
Mutation analysis of peroxisom ...... s to Type II diabetes mellitus
@en
P2093
G Andersen
K Borch-Johnsen
O Pedersen
S A Urhammer
T Drivsholm
P2888
P304
P356
10.1007/S001250100032
P407
P577
2001-12-01T00:00:00Z
P5875
P6179
1023131624